Merck Global Health Innovation Fund is a venture capital fund that invests in early-stage companies, primarily at the series A level. They focus on advanced healthcare technologies that combine biotech and artificial intelligence. Notable investments include Baseimmune. The fund writes checks ranging from $500,000 to $10,000,000, aiming to foster groundbreaking solutions in health and technology.
